Bianca Rocca: PRECISE-DAPT Score Identifies Bleeding Risk After CABG in Patients With POAF
Bianca Rocca, Editor in Chief at European Heart Journal Cardiovascular Pharmacotherapy, shared on X about a recent article by Mary Rezk et al, published in European Heart Journal – Cardiovascular Pharmacotherapy, adding:
” New in EHJ – CVP
Want something to read during your summer holidays?
Bleeding risk assessment in patients with new-onset atrial fibrillation after coronary surgery: a proof-of-concept study
Is a bleeding risk score able to identify which patients with post-operative AF after CABG are most likely to bleed after discharge?
Guidelines recommend weighing bleeding risk before starting anticoagulation, but none clearly define how to measure it.
The nationwide Swedish registry cohort included 4,436 patients with POAF after first-time isolated CABG (2009 to 2020) who did not receive oral anticoagulation at discharge, mirroring the therapeutic dilemma a clinician faces at discharge.
The four-item PRECISE-DAPT score (age, creatinine clearance, preoperative haemoglobin, previous bleeding) classified 36% of the patients as high risk.
Major bleeding during the first year occurred in 0.8% of low-risk, 1.9% of moderate-risk and 3.6% of high-risk patients, with a hazard ratio of 4.81 (95% CI 2.59 to 8.96) for high versus low risk.Discrimination was moderate (AUC 0.68) and calibration was good up to a predicted annual risk of about 7%.
This is an observational registry study. Patients on anticoagulation were excluded, so the findings apply to those judged safe to discharge without it, and registry-based definitions will miss bleeds that did not lead to hospitalisation. The score separates risk groups, but whether using it to guide anticoagulation improves outcomes will need prospective, randomized testing.”
Title: Bleeding risk assessment in patients with new-onset atrial fibrillation after coronary surgery: a proof-of-concept study
Authors: Mary Rezk, Amar Taha, Andreas Martinsson, Susanne J Nielsen, Tomas Gudbjartsson, Lennart Bergfeldt, Florian E M Herrmann, Emma C Hansson, Anders Jeppsson
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience